A fundraising campaign for a child suffering from Spinal Muscular Atrophy (SMA) Type 1 has drawn attention in Delhi after people came forward to help the family arrange money for treatment. The campaign reportedly began after social media influencer Khalifa and his friends saw the child’s mother outside AIIMS in South Delhi.
According to a report published on September 23, the campaign had collected around ₹6 crore against a reported treatment requirement of about ₹9 crore. A related social media post showed approximately ₹6.33 crore raised. Because fundraising amounts can change, the latest figure should be checked through the official campaign.
SMA Type 1 Treatment Cost Becomes a Major Challenge
The SMA Type 1 treatment cost has become the central financial challenge for the family. According to the report, the family says that the child’s treatment requires a specific injection costing more than ₹9 crore. The exact treatment plan and total medical expense for this particular child should, however, be confirmed through the treating medical team.
The fundraising effort started on a small scale outside AIIMS before expanding to Jama Masjid. People were informed about the child’s condition and asked to contribute according to their ability.
The SMA Type 1 treatment cost can become particularly difficult for families when advanced therapies are required. In such cases, fundraising can become an important way of arranging financial support.
The campaign also used a QR code for digital donations. People contributed different amounts after hearing about the child’s condition and treatment requirement.
What Is SMA Type 1?
Spinal Muscular Atrophy is a rare genetic disorder that affects motor neurons, the nerve cells responsible for controlling voluntary muscle movement. SMA Type 1 generally develops during infancy and can cause significant muscle weakness.
The condition is commonly linked to changes in the SMN1 gene, which can result in insufficient survival motor neuron protein. This affects motor neurons and can lead to progressive weakness.
Children with SMA Type 1 may experience difficulties with movement, swallowing and breathing. The severity and progression can vary, and medical care depends on the individual child’s condition.
Understanding SMA is important when discussing the SMA Type 1 treatment cost, because the treatment required is not necessarily identical for every patient.
Why Is SMA Type 1 Treatment Cost So High?
The SMA Type 1 treatment cost depends on the therapy recommended, the patient’s age and medical condition, treatment availability and other medical requirements.
Modern SMA treatment includes disease-modifying therapies such as nusinersen and risdiplam. Gene-replacement therapy is another treatment approach used for eligible patients.
Some of these therapies involve highly specialised medicines and can involve substantial expenses. This is one reason why the SMA Type 1 treatment cost can create a major financial burden for families.
Medical research has reported improved motor outcomes with several SMA treatments. However, treatment decisions need to be made by specialist doctors after considering the patient’s individual medical circumstances.
The price mentioned in a fundraising campaign should therefore not automatically be treated as the standard cost of SMA treatment. The actual SMA Type 1 treatment cost can differ between patients and treatment plans.
Fundraising Campaign Reaches Jama Masjid
The fundraising effort later reached Jama Masjid in Delhi. According to the report, Khalifa and his friends approached worshippers after Friday prayers and explained the child’s condition and financial requirement.
The organisers reportedly wore T-shirts carrying information about the mother and child and displayed a QR code to enable digital donations.
People stopped to hear the appeal and contributed according to their means. Some also offered prayers and expressed their willingness to support the family.
The campaign brought wider attention to the SMA Type 1 treatment cost and the difficulties families can face when specialised treatment requires a very large amount of money.
The Child’s Family Faces a Difficult Situation
According to the report, the child’s mother said that her daughter spends much of her time in bed and needs assistance even with basic activities such as drinking water. She also spoke about the emotional difficulty of watching children of a similar age play while her daughter remains affected by the condition.
SMA Type 1 can significantly affect movement and everyday physical activities. Some children can also require ongoing medical and supportive care for feeding, swallowing or breathing difficulties.
For this family, the SMA Type 1 treatment cost is therefore not simply a financial figure. It represents the amount they are trying to arrange to access the treatment recommended for their child.
The campaign has brought the family’s situation to a wider audience and encouraged people to consider contributing through the fundraising effort.
₹6.33 Crore Figure Appears in the Viral Post
The viral social media content associated with the story shows approximately ₹6.33 crore raised. The September 23 report from Awaz-The Voice initially described the amount as around ₹6 crore against a reported requirement of ₹9 crore. Its author listing currently displays a figure of ₹6.33 crore and a reported requirement of ₹9.7 crore, showing that figures associated with the campaign have changed or been presented differently.
This is important when discussing the SMA Type 1 treatment cost because fundraising totals can change while a campaign is active.
The ₹6.33 crore figure should therefore be treated as the amount shown in the social media material rather than a permanently verified final total.
Anyone considering donating should check the latest official fundraising information before making a contribution.
Medical Treatment for SMA Has Changed
The treatment landscape for SMA has changed considerably in recent years. Disease-modifying medicines and gene-replacement approaches have provided additional treatment options for eligible patients.
Nusinersen is one treatment used for SMA, while risdiplam is another disease-modifying medicine. Gene-replacement therapy is also used in appropriate cases.
Research has found that earlier treatment can be associated with better outcomes, particularly when treatment begins before significant motor-neuron damage has occurred.
However, these treatments are not interchangeable for every patient. A specialist medical team must determine whether a particular therapy is suitable.
This is also why the SMA Type 1 treatment cost should be considered alongside the medical plan rather than as a standalone number.
Why Early Medical Guidance Matters
SMA Type 1 can progress quickly, which makes timely medical assessment important. Doctors may consider genetic testing, clinical symptoms, disease progression and other factors when deciding on treatment.
Families may also need continuing supportive care alongside disease-modifying treatment. This can include respiratory support, nutritional assistance, physiotherapy and regular medical monitoring depending on the patient’s needs.
As a result, the overall SMA Type 1 treatment cost may involve more than the price of one medicine or injection.
Families dealing with rare diseases often have to manage medical, financial and emotional challenges at the same time. Access to accurate medical information is therefore important before making decisions about treatment or fundraising.
Medical Fundraising Requires Verification
Large medical fundraising campaigns can attract significant public attention, especially when social media posts show a large treatment target.
The campaign connected to this child has similarly received attention after people gathered at Jama Masjid to contribute towards the reported treatment requirement.
However, donors should verify the details before transferring money. This includes checking the beneficiary’s identity, medical documentation, hospital details, treatment recommendation and official fundraising account.
This is particularly important when the SMA Type 1 treatment cost is reported in crores, because a large fundraising target requires clear information about the treatment and the amount actually required.
Social media figures can also change quickly. Therefore, the latest information from the verified campaign should be considered before making a donation.
A Separate SMA Fundraising Case in Pune
The Delhi campaign should not be confused with another recent SMA Type 1 fundraising case involving a toddler named Gargi Jadhav in Pune.
A September 15 report said that the Muslim community in Wagholi had raised money for Gargi, a 14-month-old child diagnosed with SMA Type 1. That report described a separate treatment campaign and said the family was raising money for an expensive gene therapy.
The two cases are different, even though both involve SMA Type 1 and community fundraising.
This distinction is important because medical fundraising stories can involve similar treatment names, amounts and community appeals. Combining details from different cases can create inaccurate information about the SMA Type 1 treatment cost for an individual patient.
Why Community Support Has Become Important
Rare diseases can place significant financial pressure on families. When specialised treatment costs several crores, many families may need assistance from relatives, charities, crowdfunding campaigns or other sources.
The Delhi campaign demonstrates how a local appeal can expand when people share information and contribute. The fundraising effort moved from outside AIIMS to Jama Masjid and reached people who were willing to support the child.
Community support cannot replace professional medical advice, but it can help families manage financial barriers when treatment is expensive.
The SMA Type 1 treatment cost in this case has therefore become part of a larger conversation about rare diseases, access to treatment and the financial pressure faced by families.
Conclusion
The fundraising campaign for a child with SMA Type 1 has drawn attention to the financial challenges associated with rare genetic disorders. The reported SMA Type 1 treatment cost in this case runs into several crores, with the family reporting a requirement of around ₹9 crore.
The September 23 report described around ₹6 crore raised, while related social media material showed approximately ₹6.33 crore. Later information on the publisher’s page also displays different figures, so the current fundraising total should be verified through the official campaign.
The story also highlights the changing treatment landscape for SMA. Modern therapies can provide options for eligible patients, but treatment decisions must be based on specialist medical advice and the individual patient’s condition.
For the family, raising the required amount remains a major challenge. For donors, verifying the medical and fundraising information before contributing is equally important.
FAQs
What is SMA Type 1?
SMA Type 1 is a severe form of Spinal Muscular Atrophy, a genetic disorder that affects motor neurons and can cause significant muscle weakness, particularly during infancy.
What is the SMA Type 1 treatment cost in this case?
The family has reportedly stated that around ₹9 crore is required for treatment. The fundraising campaign has reported different collection figures, including around ₹6 crore and approximately ₹6.33 crore.
Is ₹9 crore the standard SMA treatment cost?
No. The SMA Type 1 treatment cost varies depending on the therapy, patient, medical condition and treatment plan. The amount reported in this case should not be treated as a standard cost for every SMA patient.
What treatments are available for SMA?
Treatment options can include medicines such as nusinersen and risdiplam and gene-replacement therapy for appropriate patients. The suitable treatment depends on the individual medical assessment.
Why are SMA treatments expensive?
Some SMA therapies involve specialised medicines or gene-replacement technology, which can involve substantial costs. Additional medical and supportive care can also contribute to overall expenses.
Follow Khabar Khojo
Follow @officialkhabarkhojo for breaking news, India news, world updates, business, markets, technology, sports, entertainment, lifestyle and exclusive stories.
Also read more of such a news on our India News
Sources
Awaz-The Voice — Delhi fundraising report
NIH MedlinePlus Genetics — SMA information
More Stories
Asarva Water Tank Incident: Remains Found, AMC Orders Probe
Silver Oak Student Death Ahmedabad: Shocking Crane Accident Tragedy
500000 Fake Gmail Accounts in India: Shocking India Case